CURE Pharmaceutical Holding Corp. filed its 10-K on Apr 01, 2022 for the period ending Dec 31, 2021. In this report its auditor, Russell Bedford Stefanou Mirchandani LLP - RBSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0388 USD | +17.07% | +5.72% | -47.85% |
1st Jan change | Capi. | |
---|---|---|
-47.85% | 2.42M | |
+12.51% | 3,096B | |
+12.68% | 85.37B | |
+7.61% | 77.1B | |
-13.71% | 54.31B | |
-22.56% | 47.92B | |
+26.21% | 47.74B | |
+25.42% | 42.15B | |
+69.48% | 38.06B | |
-8.00% | 24.73B |
- Stock Market
- Equities
- AVRW Stock
- News Avenir Wellness Solutions, Inc.
- CURE Pharmaceutical Holding Corp. Auditor Raises 'Going Concern' Doubt